Chengdu Olymvax Biopharmaceuticals, Inc.

66
Hold
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000051H8
CNY
30.38
1.32 (4.54%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Operating Income
701.00
587.00
494.00
543.00
485.00
319.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
701.00
587.00
494.00
543.00
485.00
319.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
76.00
81.00
79.00
72.00
57.00
32.00
Operating Expenses
15.00
14.00
7.00
5.00
1.00
0.00
General and Administration Expenses
448.00
375.00
312.00
352.00
295.00
220.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
641.00
550.00
465.00
520.00
387.00
283.00
Operating Profit (PBDIT) excl Other Income
59.00
36.00
28.00
23.00
97.00
35.00
Other Income
14.00
15.00
19.00
34.00
14.00
9.00
Operating Profit (PBDIT)
90.00
72.00
56.00
77.00
133.00
55.00
Interest
15.00
14.00
7.00
5.00
1.00
0.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
43.00
35.00
33.00
28.00
24.00
17.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
31.00
22.00
15.00
43.00
107.00
36.00
Provision for Tax
9.00
6.00
4.00
17.00
0.00
0.00
Profit After Tax
22.00
20.00
17.00
26.00
107.00
36.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
0.05
0.05
0.04
0.07
0.27
0.09
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 19.43% vs 18.85% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 61.90% vs 28.08% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 3.79% vs 100.72% in Dec 2024

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2025 is 7.24% vs 18.24% in Dec 2024

Compare Profit and Loss Results of Chengdu Olymvax Biopharmaceuticals, Inc.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
No of Months
12
12
Operating Income
701.00
0
701.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
701.00
0
701.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0
0.00
0%
Raw Materials Consumed
0.00
0
0.00
0%
Power & Fuel Cost
0.00
0
0.00
0%
Employee Cost
76.00
0
76.00
0%
Operating Expenses
15.00
0
15.00
0%
General and Administration Expenses
448.00
0
448.00
0%
Selling and Distribution Expenses
0.00
0
0.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
0.00
0
0.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
641.00
0
641.00
0%
Operating Profit (PBDIT) excl Other Income
59.00
0.00
59.00
0%
Other Income
14.00
0
14.00
0%
Operating Profit (PBDIT)
90.00
0
90.00
0%
Interest
15.00
0
15.00
0%
Profit before Depriciation and Tax
0.00
0
0.00
0%
Depreciation
43.00
0
43.00
0%
Profit Before Taxation & Exceptional Items
0.00
0
0.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
31.00
0
31.00
0%
Provision for Tax
9.00
0
9.00
0%
Profit After Tax
22.00
0
22.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
0.00
0
0.00
0%
Profit Available for appropriations
0.00
0
0.00
0%
Appropriations
0.00
0
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0.0549
0
0.05
0%
Profit And Loss - Net Sales
Net Sales 701.54 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 19.43% vs 18.85% in Dec 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 59.61 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 61.90% vs 28.08% in Dec 2024

Profit And Loss - Interest
Interest 15.07 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 3.79% vs 100.72% in Dec 2024

Profit And Loss - Profit After Tax
Profit After Tax 22.26 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 7.24% vs 18.24% in Dec 2024